Last week the government drug regulatory authority Drugs Controller General of India (DCGI) recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/IiF86U3
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» NTAGI holds meeting on Covovax inclusion as heterologous booster on CoWin portal
https://ift.tt/7OBaoSJ
No comments:
Post a Comment